Meal frequency and timing in health and disease
Water fasting and decreased metabolic-syndrome
Metabolic management of microenvironment acidity in glioblastoma
Metabolic therapy and bioenergetic analysis
Cancer as a metabolic disease
Mitochondrial Substrate-Level Phosphorylation as Energy Source for Glioblastoma
Metabolic therapy: a new paradigm for managing malignant brain cancer
Targeting energy metabolism in brain cancer with calorically restricted ketogenic diets
Metabolic management of brain cancer
On the Origin of ATP Synthesis in Cancer
On the origin of cancer metastasis
Optimal Dosing and Prodrug Delivery of 6-Diazo-5-oxo-L-norleucine
Glucose ketone index for monitoring therapeutic efficacy for metabolic management of brain cancer
Mitochondrial dysfunction and oxidative stress in neurodegenerative diseases
Assessing mitochondrial dysfunction in cells
Repairing Mitochondrial Dysfunction in Disease
Mitochondrial dysfunction and mitochondrial dynamics-The cancer connection
Glutamine blockade induces divergent metabolic programs to overcome tumor immune evasion
Targeting glutamine metabolism enhances tumor-specific immunity by modulating suppressive myeloid cells
Pharmacological inhibition of cystine–glutamate exchange induces endoplasmic reticulum stress
Targeting Glutamine Metabolism to Enhance Immunoprevention of EGFR-Driven Lung Cancer
Novel Prodrugs of 6-Diazo-5-Oxo-L-Norleucine With More Brain Delivery
Mitochondria and Cancer
Dr. Rana Rais – Video, glutamine antagonist prodrug development at JHU